Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$860
|
$802B |
16.1x |
41.5x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$155
|
$386B |
4.3x |
12.0x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$180
|
$381B |
6.6x |
14.8x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$80
|
$224B |
3.5x |
8.2x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$280
|
$198B |
5.8x |
10.1x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$23
|
$172B |
2.7x |
7.1x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$106
|
$147B |
5.1x |
12.3x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$49
|
$139B |
2.9x |
12.5x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$492
|
$122B |
10.8x |
53.2x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$152
|
$72.7B |
7.8x |
18.3x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$600
|
$59.3B |
4.2x |
11.0x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$243
|
$30.0B |
12.2x |
234.5x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$37
|
$26.7B |
N/A |
-102.5x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$22.8B |
1.6x |
5.1x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$120
|
$21.7B |
2.3x |
6.5x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$69
|
$12.3B |
30.9x |
-13.8x |
Biomarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$63
|
$11.5B |
3.9x |
16.7x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$12
|
$11.3B |
1.8x |
5.8x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$296
|
$10.3B |
3.5x |
6.5x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$121
|
$10.2B |
3.7x |
-7.7x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$106
|
$9.8B |
4.0x |
14.5x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$109
|
$9.8B |
2.4x |
5.1x |
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$37
|
$9.3B |
4.3x |
13.1x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$59
|
$9.3B |
2.1x |
19.9x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$9
|
$8.5B |
1.9x |
9.6x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$59
|
$8.2B |
7.7x |
12.1x |
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$36
|
$7.9B |
34.7x |
-13.5x |
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$72
|
$7.2B |
9.6x |
N/A |
Lantheus Holdings
|
United States of America |
Medical Imaging & Diagnostics,
Drug Development & Therapeutics
|
$104
|
$6.8B |
4.4x |
9.8x |
Perrigo
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$25
|
$6.5B |
1.5x |
8.8x |
TG Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$40
|
$6.3B |
15.7x |
68.8x |
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$320
|
$6.3B |
20.4x |
-13.2x |
Sarepta Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$62
|
$6.0B |
2.6x |
12.6x |
Legend Biotech
|
United States of America |
Drug Development & Therapeutics
|
$34
|
$5.5B |
7.3x |
-31.0x |
Blueprint Medicines
|
United States of America |
Drug Development & Therapeutics
|
$86
|
$5.4B |
9.3x |
-39.1x |
PTC Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$50
|
$5.2B |
6.7x |
-27.4x |
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$39
|
$5.0B |
2172.3x |
-6.5x |
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$105
|
$5.0B |
10.9x |
-23.1x |
Prestige Consumer Healthcare
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$80
|
$4.9B |
4.3x |
13.2x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$4.8B |
1.7x |
7.5x |
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$40
|
$4.5B |
181.1x |
-8.0x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$27
|
$4.3B |
1.5x |
-1.1x |
Krystal Biotech
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$169
|
$4.3B |
12.6x |
34.1x |
Nuvalent
|
United States of America |
Drug Development & Therapeutics
|
$74
|
$4.2B |
N/A |
-14.2x |
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$28
|
$3.9B |
2.6x |
9.9x |
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$30
|
$3.8B |
5.6x |
-8.1x |
Rhythm Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$63
|
$3.8B |
25.9x |
-16.1x |
Endo
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$21
|
$3.7B |
N/A |
N/A |
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$3.7B |
6.8x |
24.4x |
Soleno Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$74
|
$3.5B |
271.7x |
N/A |
Procaps Group
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$1
|
$3.4B |
N/A |
N/A |
SpringWorks Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$45
|
$3.1B |
12.8x |
-12.4x |
Arcellx
|
United States of America |
Drug Development & Therapeutics
|
$64
|
$3.0B |
29.7x |
-19.7x |
Ultragenyx
|
United States of America |
Drug Development & Therapeutics
|
$38
|
$3.0B |
5.0x |
-6.4x |
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$34
|
$2.9B |
346.5x |
-11.3x |
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$11
|
$2.8B |
21.0x |
-2.7x |
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$2.7B |
66.5x |
N/A |
Akero Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$41
|
$2.6B |
N/A |
-8.4x |
Merus
|
United States of America |
Drug Development & Therapeutics
|
$44
|
$2.5B |
66.6x |
-9.2x |
Certara
|
United States of America |
Health Data & Analytics,
Drug Development & Therapeutics
|
$14
|
$2.5B |
6.2x |
19.7x |
Metsera
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$21
|
$2.4B |
N/A |
N/A |
Amicus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$7
|
$2.4B |
4.3x |
39.6x |
Protagonist Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$45
|
$2.3B |
7.2x |
16.6x |
Ascentage Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$26
|
$2.3B |
20.0x |
-35.9x |
Catalyst Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$23
|
$2.3B |
4.5x |
9.4x |
Xenon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$38
|
$2.3B |
3298.8x |
-7.7x |
Apellis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$18
|
$2.3B |
2.8x |
-16.8x |
Avidity Biosciences
|
United States of America |
Drug Development & Therapeutics
|
$31
|
$2.2B |
225.2x |
-5.3x |
BioCryst Pharma
|
United States of America |
Drug Development & Therapeutics
|
$8
|
$2.2B |
4.5x |
127.0x |
Immunovant
|
United States of America |
Drug Development & Therapeutics
|
$15
|
$2.2B |
3345.2x |
-5.0x |
MoonLake
|
United States of America |
Drug Development & Therapeutics
|
$39
|
$2.1B |
N/A |
-12.6x |
Vericel
|
United States of America |
Regenerative Medicine,
Drug Development & Therapeutics
|
$41
|
$2.0B |
8.1x |
34.4x |
Mirum Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$40
|
$2.0B |
5.6x |
-37.9x |
Viking Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$2.0B |
4124.5x |
-12.2x |
ANI Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$70
|
$2.0B |
3.0x |
11.9x |
Biohaven
|
United States of America |
Drug Development & Therapeutics
|
$23
|
$1.9B |
332.5x |
-2.4x |
Tarsus Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$50
|
$1.9B |
7.7x |
-19.6x |
Ligand Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$109
|
$1.8B |
10.6x |
26.3x |
Recursion Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Bioinformatics
|
$6
|
$1.8B |
27.8x |
-3.8x |
Crinetics Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$33
|
$1.8B |
724.3x |
-5.1x |
Arrowhead Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$13
|
$1.8B |
10.6x |
-3.8x |
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$60
|
$1.8B |
338.8x |
N/A |
Kymera Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$34
|
$1.8B |
36.2x |
-6.4x |
ACADIA Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$15
|
$1.8B |
1.8x |
9.2x |
CRISPR Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$39
|
$1.7B |
39.0x |
-3.9x |
Schrödinger
|
United States of America |
Healthcare Software,
Drug Development & Therapeutics
|
$26
|
$1.7B |
7.4x |
-9.2x |
BGM Group
|
United States of America |
Drug Development & Therapeutics
|
$12
|
$1.7B |
N/A |
N/A |
Apogee Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$37
|
$1.6B |
N/A |
-6.8x |
Arcutis Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$15
|
$1.6B |
7.1x |
-14.4x |
Travere Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$18
|
$1.6B |
5.8x |
-9.2x |
Amphastar Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$24
|
$1.6B |
2.1x |
5.6x |
Collegium Pharmaceutical
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$27
|
$1.6B |
2.3x |
3.8x |
Denali Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$15
|
$1.5B |
148.7x |
-3.1x |
Phibro Animal Health
|
United States of America |
Drug Development & Therapeutics
|
$18
|
$1.5B |
1.2x |
9.1x |
Harmony Biosciences Hldgs
|
United States of America |
Drug Development & Therapeutics
|
$29
|
$1.4B |
1.9x |
5.5x |
Pacira BioSciences
|
United States of America |
Drug Development & Therapeutics,
Medical Devices
|
$26
|
$1.4B |
1.9x |
6.2x |
Beam Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$20
|
$1.3B |
21.1x |
-3.2x |
Supernus Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$31
|
$1.3B |
2.0x |
8.3x |
MannKind
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$5
|
$1.3B |
4.3x |
N/A |
Kiniksa Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$21
|
$1.3B |
2.7x |
-81.4x |